Santa Fe Partners’s ResMed RMD Stock Holding History

Santa Fe Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-20,733	Closed	-$1.11M	–	255
2015 Q4	$1.11M	Buy	+20,733	New	+$1.17M	0.18%	221

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Santa Fe Partners's RMD Position: Q1 2016 in Review

Santa Fe Partners sold out of ResMed (RMD) in Q1 2016, closing a stake of 20,733 shares — an estimated $1.11M sold.

Santa Fe Partners first reported a position in RMD in Q4 2015 and held it in 1 quarter. The position peaked at $1.11M in Q4 2015. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2016.

Santa Fe Partners reported no remaining ResMed position as of Q1 2016 after selling out during the quarter.
Santa Fe Partners sold 20,733 ResMed shares in Q1 2016, an estimated $1.11M.
Santa Fe Partners first reported a position in ResMed in Q4 2015 and held it in 1 quarter.
Santa Fe Partners's ResMed position peaked at $1.11M in Q4 2015.
374 funds tracked by Wall St. Rank held ResMed as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.